Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 4
Submit an article Journal homepage
1,389
Views
67
CrossRef citations to date
0
Altmetric
Research Article

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi

Francesco MerliHematology Unit, Oncology Department, Azienda Ospedaliera Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, ItalyCorrespondence[email protected]
,
Stefano LuminariOncology and Hematology Department, University of Modena e Reggio Emilia, Italy
,
Giuseppe RossiHematology Unit, Spedali Civili, Brescia, Italy
,
Caterina MammiHematology Unit, Oncology Department, Azienda Ospedaliera Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, Italy
,
Luigi MarcheselliOncology and Hematology Department, University of Modena e Reggio Emilia, Italy
,
Alessandra TucciHematology Unit, Spedali Civili, Brescia, Italy
,
Fiorella IlariucciHematology Unit, Oncology Department, Azienda Ospedaliera Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, Italy
,
Annalisa ChiappellaDivision of Hematology, Department of Oncology, Azienda Ospedaliero – Universitaria S. Giovanni Battista, Torino, Italy
,
Maurizio MussoOncohematology Unit, Casa di Cura “La Maddalena”, Palermo, Italy
,
Alice Di RoccoDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Roma, Italy
,
Caterina StelitanoDivision of Hematology, Presidio. Ospedali Riuniti – “Bianchi, Melacrino, Morelli”, Reggio Calabria, Italy
,
Isabel AlvarezHematology Unit, Oncology Department, Azienda Ospedaliera Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, Italy
,
Luca BaldiniHematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milano, Milano, Italy
,
Patrizio MazzaHematology, Ospedale Moscati, Taranto, Italy
,
Flavia SalviHematology, A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
,
Annalisa ArcariHematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
,
Alberto FragassoInternal Medicine Department, Hematology Unit, Ospedale Madonna delle Grazie, Matera, Italy
,
Paolo G. GobbiInternal Medicine, Medical Oncology, University of Pavia, IRCCS, Pavia, Italy
,
Anna Marina LiberatiOncohematology and Autotransplant, Azienda Ospedaliera S. Maria, Terni, Italy
&
Massimo FedericoOncology and Hematology Department, University of Modena e Reggio Emilia, Italy
 show all
Pages 581-588 | Received 26 Jul 2011, Accepted 04 Sep 2011, Published online: 27 Apr 2012

Citations (67)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Baech, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen & Thomas Stauffer Larsen. (2022) Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study. Leukemia & Lymphoma 63:9, pages 2074-2083.
Read now
R. Andrew Harkins, Andres Chang, Sharvil P. Patel, Michelle J. Lee, Jordan S. Goldstein, Selin Merdan, Christopher R. Flowers & Jean L. Koff. (2019) Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma. Expert Review of Hematology 12:11, pages 959-973.
Read now
Kensuke Kayamori, Katsuhiro Shono, Masahiro Onoda & Akira Yokota. (2019) Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma. Hematology 24:1, pages 52-59.
Read now
Sara Beygi, Santhosh Sadashiv, James B Reilly, Cyrus Khan & John Lister. (2018) Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era. Leukemia & Lymphoma 59:12, pages 2847-2861.
Read now
Annalisa Chiappella, Alessia Castellino, Maura Nicolosi, Elisa Santambrogio & Umberto Vitolo. (2017) Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives. Expert Review of Hematology 10:4, pages 289-297.
Read now
Pier Luigi Zinzani, Massimo Federico, Stefano Oliva, Antonello Pinto, Luigi Rigacci, Giorgina Specchia, Alessandra Tucci & Umberto Vitolo. (2015) The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 56:1, pages 12-25.
Read now
Francesco Merli, Stefano Luminari, Giuseppe Rossi, Caterina Mammi, Luigi Marcheselli, Angela Ferrari, Michele Spina, Alessandra Tucci, Caterina Stelitano, Isabella Capodanno, Alberto Fragasso, Luca Baldini, Chiara Bottelli, Elisa Montechiarello, Stefano Fogazzi, Cinzia Lamorgese, Lara Cavalli & Massimo Federico. (2014) Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia & Lymphoma 55:1, pages 38-43.
Read now
Fabrice Jardin & Hervé Tilly. (2012) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone: until what age?. Leukemia & Lymphoma 53:4, pages 521-522.
Read now

Articles from other publishers (59)

Amelie Stueger, Markus Joerger & Katelijne De Nys. (2023) Geriatric evaluation methods in oncology and their use in clinical studies: A systematic literature review. Journal of Geriatric Oncology, pages 101684.
Crossref
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, Federica Cavallo, Stefano Luminari, Sara Veronica Usai, Alberto Fabbri, Elsa Pennese, Dario Marino, Vittorio Ruggero Zilioli, Monica Balzarotti, Luigi Petrucci, Agostino Tafuri, Annalisa Arcari, Barbara Botto, Manuela Zanni, Stefan Hohaus, Roberto Sartori, Michele Merli, Guido Gini, Wael Al Essa, Gerardo Musurca, Monica Tani, Luca Nassi, Rosa Daffini, Caterina Mammi, Luigi Marcheselli, Monica Bocchia, Michele Spina & Francesco Merli. (2022) The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi. Hematological Oncology 41:1, pages 78-87.
Crossref
Li Li, Rongrong Chen, De Zhou, Jianai Sun, Lulu Wang, Lixia Zhu, Huafei Shen, Wanzhuo Xie & Xiujin Ye. (2022) The efficacy and cardiac toxicity of different‐dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma. Cancer Medicine 12:4, pages 4184-4194.
Crossref
Yangyang Wang, Xiyang Ren, Keke Huang, Xue Liang, Lianfang Pu, Linhui Hu & Zhimin Zhai. (2023) Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis. Frontiers in Immunology 13.
Crossref
Ting Li, Jiesen Yu, Mengyuan Hou, Sijie Zha, Qingqing Cheng, Qingshan Zheng & Lujin Li. (2023) Quantitative evaluation of therapy options for relapsed/refractory diffuse large B-cell lymphoma: A model-based meta-analysis. Pharmacological Research 187, pages 106592.
Crossref
Christopher R. Flowers & Oreofe O. Odejide. (2022) Sequencing therapy in relapsed DLBCL. Hematology 2022:1, pages 146-154.
Crossref
Joel Wight, Nada Hamad, Belinda A. Campbell, Matthew Ku, Kenneth Lee, Hannah Rose, Tasman Armytage, Maya Latimer, Hui‐Peng Lee, Sze‐Ting Lee, Michael Dickinson, Richard Khor & Emma Verner. (2022) Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 52:9, pages 1609-1623.
Crossref
Kana Miyazaki. (2022) Management of elderly patients with malignant lymphoma. Japanese Journal of Clinical Oncology 52:7, pages 690-699.
Crossref
R. Andrew HarkinsSharvil P. Patel, Michelle J. LeeJeffrey M. Switchenko, Stephen M. AnsellNancy L. Bartlett, Kristie A. BlumAmanda F. CashenCarla Casulo, Jonathan W. FriedbergPatrick B. JohnstonBrad S. Kahl, John P. LeonardBrian K. Link, Izidore S. Lossos, Peter MartinMatt J. Maurer, Neha Mehta-Shah, Patrick M. ReaganJason R. Westin, Jean L. Koff & Christopher R. Flowers. (2022) Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood Advances 6:9, pages 2745-2756.
Crossref
Jérémie Vovelle, Céline Row, Fabrice Larosa, Julien Guy, Anca-Maria Mihai, Marc Maynadié, Jérémy Barben & Patrick Manckoundia. (2022) Prescription of Blood Lymphocyte Immunophenotyping in the Diagnosis of Lymphoid Neoplasms in Older Adults. Journal of Clinical Medicine 11:6, pages 1748.
Crossref
Mengyang Di, Tamra Keeney, Emmanuelle Belanger, Orestis A. Panagiotou & Adam J. Olszewski. (2022) Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study. JCO Oncology Practice 18:3, pages e383-e402.
Crossref
Elizabeth A. Brem, Hongli Li, Anne W. Beaven, Paolo F. Caimi, Leandro Cerchietti, Ash A. Alizadeh, Rebecca Olin, N. Lynn Henry, Hildy Dillon, Richard F. Little, Cara Laubach, Michael LeBlanc, Jonathan W. Friedberg & Sonali M. Smith. (2022) SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool. Journal of Geriatric Oncology 13:2, pages 258-264.
Crossref
Kathrine T. Isaksen, Maria Adele MastroianniMarit RindeLeiv Sindre RustenDlawer Abdulla BarzenjeLloyd Frode RamslienMarit SlaaenMarianne Brenn JermErlend B. SmelandSiri Rostoft, Knut Liestøl, Marianne Brodtkorb & Harald Holte. (2021) A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL. Blood Advances 5:22, pages 4771-4782.
Crossref
Madison Keenan, Akiva Diamond, Kirsten Boughan, Brenda Cooper, Molly Gallogly, Ehsan Malek, Leland Metheny, Timothy O'Brien, Folashade Otegbeye, Benjamin Tomlinson, Marcos de Lima & Paolo F. Caimi. (2021) Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates. Clinical Lymphoma Myeloma and Leukemia 21:11, pages 799-804.
Crossref
Francesco Merli, Stefano Luminari, Alessandra Tucci, Annalisa Arcari, Luigi Rigacci, Eliza Hawkes, Carlos S. Chiattone, Federica Cavallo, Giuseppina Cabras, Isabel Alvarez, Alberto Fabbri, Alessandro Re, Benedetta Puccini, Allison Barraclough, Marcia Torresan Delamain, Simone Ferrero, Sara Veronica Usai, Angela Ferrari, Emanuele Cencini, Elsa Pennese, Vittorio Ruggero Zilioli, Dario Marino, Monica Balzarotti, Maria Christina Cox, Manuela Zanni, Alice Di Rocco, Arben Lleshi, Barbara Botto, Stefan Hohaus, Michele Merli, Roberto Sartori, Guido Gini, Luca Nassi, Gerardo Musuraca, Monica Tani, Chiara Bottelli, Sofia Kovalchuk, Francesca Re, Leonardo Flenghi, Annalia Molinari, Giuseppe Tarantini, Emanuela Chimienti, Luigi Marcheselli, Caterina Mammi & Michele Spina. (2021) Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. Journal of Clinical Oncology 39:11, pages 1214-1222.
Crossref
Alda Tavares & Ilídia Moreira. (2021) Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review. Critical Reviews in Oncology/Hematology 160, pages 103294.
Crossref
Mengyang Di, Scott F Huntington & Adam J. Olszewski. (2021) Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. The Oncologist 26:2, pages 120-132.
Crossref
Pierre-Louis Soubeyran. 2020. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 1 10 .
Pierre-Louis Soubeyran. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 5251 5260 .
Pamela Allen. (2020) Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches. Current Oncology Reports 22:11.
Crossref
Jie Zhu, Yong Yang, Jin Tao, Shu-Lian Wang, Bo Chen, Jian-Rong Dai, Chen Hu, Shu-Nan Qi & Ye-Xiong Li. (2020) Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review. Leukemia 34:10, pages 2576-2591.
Crossref
Osama M. Al-Quteimat. (2020) Vincristine Shortage: What Other Options We Have?. American Journal of Clinical Oncology 43:2, pages 146-147.
Crossref
Vicki A. Morrison. 2020. Geriatric Oncology. Geriatric Oncology 583 612 .
Doen Ming Ong, Michael Ashby, Andrew Grigg, Grace Gard, Zi Y. Ng, Huayi (Ellen) Huang, Yee Shuen Chong, Chan Yoon Cheah, Bianca Devitt, Geoffrey Chong, Zoe Loh, Allison Mo & Eliza A. Hawkes. (2019) Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B‐cell lymphoma receiving rituximab‐chemotherapy combinations. British Journal of Haematology 187:1, pages 73-81.
Crossref
Stephanie Guidez, Laurence Lacotte‐Thierry, Cecile Tomowiak, Isabelle Princet, Brigitte Dreyfus, Gaelle Olivier, Emmanuel Fleck, Anne Corby, Carine Motard, Jocelyn Barrier, Antoine Machet, Katell Le Dû, Celine Debiais‐Delpech, Michele Chabin, Xavier Leleu, Joëlle Guilhot & Vincent Delwail. (2019) Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma. British Journal of Haematology 186:6.
Crossref
Pierre-Louis Soubeyran & Raul Cordoba. (2019) Approaches for vulnerable and frail older patients with diffuse large B-cell lymphomas. Current Opinion in Oncology 31:5, pages 369-373.
Crossref
Peng Liu, Ying Han, Shi-Yu Jiang, Xiao-Hui He, Yan Qin, Lin Gui, Sheng-Yu Zhou, Li-Qiang Zhou, Jian- Liang Yang, Sheng Yang, Ting-Yu Wen & Yuan-Kai Shi. (2019) A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma. Chinese Medical Journal 132:15, pages 1807-1814.
Crossref
Yasir Khan & Elizabeth A. Brem. (2019) Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly. Current Hematologic Malignancy Reports 14:4, pages 228-238.
Crossref
T. Wästerlid, M. Mohammadi, K. E. Smedby, I. Glimelius, M. Jerkeman, M. Bottai & S. Eloranta. (2018) Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B‐cell lymphoma: a Swedish lymphoma register study. Journal of Internal Medicine 285:4, pages 455-468.
Crossref
Feng Zhang, Xuanchu Duan & Ke Liu. (2019) A case report of an extranodal NK/T-cell lymphoma nasal type, occurring primarily in eyes with masquerade syndrome. Medicine 98:11, pages e14836.
Crossref
Masatoshi Sakurai, Daiki Karigane, Hidenori Kasahara, Tomohiko Tanigawa, Akaru Ishida, Hiroshi Murakami, Masao Kikuchi & Sumiko Kohashi. (2018) Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma. Annals of Hematology 98:3, pages 669-678.
Crossref
Alden A. Moccia & Catherine Thieblemont. (2018) Curing diffuse large B-cell lymphomas in elderly patients. European Journal of Internal Medicine 58, pages 14-21.
Crossref
Abhijeet Kumar, Muhammad Asad Fraz, Muhammad Usman, Saad Ullah Malik, Awais Ijaz, Ceren Durer, Seren Durer, Muhammad Junaid Tariq, Ali Younas Khan, Anum Qureshi, Warda Faridi, Aboo Nasar & Faiz Anwer. (2018) Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients. Current Treatment Options in Oncology 19:10.
Crossref
Qian ShiNorbert SchmitzFang-Shu OuJesse G. DixonDavid CunninghamMichael PfreundschuhJohn F. SeymourUlrich JaegerThomas M. HabermannCorinne HaiounHervé TillyHervé GhesquieresFrancesco MerliMarita ZiepertRaoul HerbrechtJocelyne FlamentTommy FuBertrand CoiffierChristopher R. Flowers. (2018) Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient–Level Analysis of Multiple Randomized Trials (SEAL). Journal of Clinical Oncology 36:25, pages 2593-2602.
Crossref
M.J. Maurer, T.M. Habermann, Q. Shi, N. Schmitz, D. Cunningham, M. Pfreundschuh, J.F. Seymour, U. Jaeger, C. Haioun, H. Tilly, H. Ghesquieres, F. Merli, M. Ziepert, R. Herbrecht, J. Flament, T. Fu, C.R. Flowers & B. Coiffier. (2018) Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials. Annals of Oncology 29:8, pages 1822-1827.
Crossref
Maja Bech Juul, Pernille Hammershoej Jensen, Henriette Engberg, Sonja Wehberg, Andriette Dessau-Arp, Donika Haziri, Helene Bjoerg Kristensen, Joachim Baech, Lene Schurmann, Michael Roost Clausen, Rebecca Valentin, Lene Meldgaard Knudsen, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen & Thomas Stauffer Larsen. (2018) Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study. European Journal of Cancer 99, pages 86-96.
Crossref
Chieh-Lung Cheng, Jia-Hau Liu, Sheng-Chieh Chou, Ming Yao, Jih-Luh Tang & Hwei-Fang Tien. (2018) Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma. European Journal of Haematology 101:1, pages 28-37.
Crossref
Andrés José María Ferreri. (2018) Seeking solutions to old problems in elderly patients with lymphoma. The Lancet Haematology 5:6, pages e235-e236.
Crossref
Stefania Gobba, Alden A. Moccia, Wiebke Gulden-Sala, Annarita Conconi, Stefan Diem, Luciano Cascione, Gloria Iacoboni, Gloria Margiotta-Casaluci, Kathrin Aprile von Hohenstaufen, Anastasios Stathis, Felicitas Hitz, Graziella Pinotti, Gianluca Gaidano & Emanuele Zucca. (2018) Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with “standard” immunochemotherapy: A large retrospective study from 4 institutions. Hematological Oncology 36:1, pages 84-92.
Crossref
Giuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, Elena Ranucci, Massimo Federico, Marta Di Nicola, Isaia Antonio Luca Zecca & Francesco Angrilli. (2018) Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study. Hematological Oncology 36:1, pages 44-48.
Crossref
Vicki A. Morrison. 2018. Geriatric Oncology. Geriatric Oncology 1 31 .
Daniel J. Sargent, Qian Shi, Christopher R. Flowers, Norbert Schmitz, Thomas M. Habermann, Jocelyne Flament, Tommy Fu & Bertrand Coiffier. (2017) The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project. The Oncologist 22:12, pages 1415-1418.
Crossref
Richard J. Lin, Madhusmita Behera, Catherine S. Diefenbach & Christopher R. Flowers. (2017) Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma. Blood 130:20, pages 2180-2185.
Crossref
Karin Ribi, Stéphanie Rondeau, Felicitas Hitz, Ulrich Mey, Milica Enoiu, Thomas Pabst, Anastasios Stathis, Natalie Fischer & Kerri M. Clough-Gorr. (2017) Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma. Supportive Care in Cancer 25:9, pages 2833-2842.
Crossref
Shih-Feng Cho, Yi-Chang Liu, Hui-Hua Hsiao, Chiung-Tang Huang, Yu-Fen Tsai, Hui-Ching Wang, Sheng-Fung Lin & Ta-Chih Liu. (2017) Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma. Scientific Reports 7:1.
Crossref
Paolo F. Caimi, Brian T. Hill, Eric D. Hsi & Mitchell R. Smith. (2016) Clinical approach to diffuse large B cell lymphoma. Blood Reviews 30:6, pages 477-491.
Crossref
Ja Min Byun, Jeong-Ok Lee, Beodeul Kang, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Soo-Mee Bang & Jong Seok Lee. (2016) Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population. Clinical Lymphoma Myeloma and Leukemia 16:9, pages 503-510.e3.
Crossref
Felicitas Hitz, Emanuele Zucca, Thomas Pabst, Natalie Fischer, Anne Cairoli, Panagiotis Samaras, Clemens B. Caspar, Nicolas Mach, Fatime Krasniqi, Adrian Schmidt, Christian Rothermundt, Milica Enoiu, Katrin Eckhardt, Simona Berardi Vilei, Stephanie Rondeau & Ulrich Mey. (2016) Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British Journal of Haematology 174:2, pages 255-263.
Crossref
Yun Hwa Jung, In Sook Woo & Chi Wha Han. (2015) Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review. The Korean Journal of Internal Medicine 30:5, pages 684-693.
Crossref
Takaaki Yamada. (2015) Pharmacological Study and Pharmaceutical Intervention to Reduce Intravenous Injection-induced Vascular Injury注射剤による血管障害の発現回避に向けた薬理学的検討並びに薬学的介入. YAKUGAKU ZASSHI 135:3, pages 465-472.
Crossref
C Benavente, C Serí, B Iñigo & R Martínez. (2015) Lymphoma in older patients: clinical and therapeutic characteristics. Reviews in Clinical Gerontology 25:1, pages 1-11.
Crossref
Martine Extermann. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 219 237 .
Nils Winkelmann & Ulrich Wedding. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 185 202 .
Stephan Kreher, Felicitas Lammer, Dieter Augustin, Antonio Pezzutto & Claudia D. Baldus. (2014) R‐split‐ CHOP chemotherapy for elderly patients with diffuse large B‐cell lymphoma . European Journal of Haematology 93:1, pages 70-76.
Crossref
Tanya M. WildesValentin GoedePaul Hamlin. (2014) Personalizing Therapy for Older Adults with Lymphoid Malignancies: Options and Obstacles. American Society of Clinical Oncology Educational Book:34, pages e240-e248.
Crossref
M.T.E. Puts, B. Santos, J. Hardt, J. Monette, V. Girre, E.G. Atenafu, E. Springall & S.M.H. Alibhai. (2014) An update on a systematic review of the use of geriatric assessment for older adults in oncology. Annals of Oncology 25:2, pages 307-315.
Crossref
Stephen D. Smith, Andy Chen, Stephen Spurgeon, Craig Okada, Guang Fan, Jennifer Dunlap, Rita Braziel & Richard Maziarz. (2013) Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors. Therapeutic Advances in Hematology 4:6, pages 349-353.
Crossref
Clémentine Sarkozy & Bertrand Coiffier. (2013) Diffuse Large B-cell Lymphoma in the Elderly: A Review of Potential Difficulties. Clinical Cancer Research 19:7, pages 1660-1669.
Crossref
Tung-Liang Lin, Ming-Chung Kuo, Lee-Yung Shih, Po Dunn, Po-Nan Wang, Jin-Hou Wu, Tzung-Chih Tang, Hung Chang & Yu-Shin Hung. (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Annals of Hematology 91:9, pages 1383-1391.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.